Jin Medical International Ltd's ROA from the fourth quarter of 2025 to the fourth quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Jin Medical International Ltd's ROA in the fourth quarter of 2025?
Jin Medical International Ltd achieved a return on average assets (ROA) of 2.71 % in its fourth quarter of 2025, which is below Jin Medical International Ltd's average return on assets, which stands at 5.03%.

ROA fell compared to the third quarter of 2025, despite the net income growth of % from the third quarter of 2025.

However, within the Healthcare sector 183 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 1695.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Sep 30 2023) IV. Quarter
Y / Y Total Assets Change	33.24 %	33.73 %	62.2 %	46.99 %	21.73 %
Y / Y Net Income Change	-52.01 %	-	-	-	-
Net Income (TTM) in million	1	3	3	3	3
Return On Assets (TTM)	2.71 %	6.03 %	6.45 %	7.29 %	8.08 %
ZJYL's Total Ranking	# 1695	#	#	#	# 874
Total Assets (TTM) in million	53	49	53	48	40
Seq. Total Assets Change	8.34 %	-7.7 %	10.82 %	20.24 %	8.74 %
Seq. Net Income Change	-	-	-	-	-

ZJYL's 5 Years Annual ROA >> Back to ZJYL Management Effectiveness >> Compare ZJYL ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 56
Sector	# 184
Overall	# 1681

Return On Assets Statistics
High	Average	Low
7.47 %	5.03 %	2.59 %
(Sep 30 2024)		(Sep 30 2025)

Financial Statements
Jin Medical International Ltd's Assets	$ 53 million	ZJYL's Balance sheet
Jin Medical International Ltd's Income	$ 1 million	Quarterly ZJYL's Income Statement
ZJYL's Income by Division		See ZJYL's Income by Division

Annual Return On Assets	(Sep 30 2025) FY 2025	(Sep 30 2024) FY 2024	(Sep 30 2023) FY 2023	FY	FY
Y / Y Total Assets Change	22.98 %	21.41 %	-	-	-
Total Assets in million	49	40	33	0	0
Y / Y Net Income Change	-59.61 %	18.82 %	-	-	-
Net Income in million	1	3	3	0	0
Annual Return On Assets	2.8 %	8.54 %	8.72 %	-	-

ZJYL's 5 Years Annual ROA >> Back to ZJYL Management Effectiveness >> Compare ZJYL ROA to its Competitors

Comment on ZJYL's ROA in the fiscal year ending 2025

In the fiscal year 2025 Jin Medical International Ltd's ROA decreased compared to previous year to 2.8 %, due to deterioration of net income -59.61 % to $1.38 million, from $3.42 million a year ago, as ZJYL's assets were $49.26 million.

More Return On Assets Ratios
ZJYL's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ZJYL's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ZJYL's Competitors
Subscribers only: Roa for Jin Medical International Ltd's Suppliers
Subscribers only: Return On Assets for ZJYL's Customers

You may also want to know
ZJYL's Roi	ZJYL's Inventory Turnover Ratio	ZJYL's Growth Rates	ZJYL's Dividend Comparisons
	ZJYL's Profitability Ratios	ZJYL's Asset Turnover Ratio	ZJYL's Dividend Growth
ZJYL's Roe	ZJYL's Valuation Ratios	ZJYL's Financial Strength Ratios	ZJYL's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2025, within Healthcare Sector	ROA
Biomarin Pharmaceutical Inc	7.13 %
Haemonetics Corporation	7.04 %
Protalix Biotherapeutics inc	7.00 %
Amphastar Pharmaceuticals Inc	6.89 %
Mannkind Corporation	6.84 %
Boston Scientific Corporation	6.80 %
Royalty Pharma Plc	6.77 %
Kewaunee Scientific Corporation	6.76 %
Ensign Group Inc	6.71 %
National Healthcare Corp	6.67 %
Ge Healthcare Technologies Inc	6.62 %
Steris Plc	6.57 %
Tactile Systems Technology Inc	6.54 %
Gyre Therapeutics Inc	6.51 %
Stryker Corp	6.46 %
Hologic Inc	6.45 %
Bristol myers Squibb Company	6.42 %
Quest Diagnostics Inc	6.40 %
Protagonist Therapeutics inc	6.32 %
Davita Inc	6.32 %
Cadre Holdings inc	6.27 %
Option Care Health Inc	6.16 %
Align Technology inc	6.11 %
Addus Homecare Corp	6.06 %
Nature s Sunshine Products inc	6.00 %
Ardent Health Inc	5.92 %
Concentra Group Holdings Parent Inc	5.83 %
Biogen Inc	5.66 %
Inspire Medical Systems inc	5.66 %
Kiniksa Pharmaceuticals International Plc	5.63 %

Date modified: 2026-07-07T14:09:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.